Ignite Creation Date:
2025-12-26 @ 2:43 PM
Ignite Modification Date:
2026-02-24 @ 3:15 PM
Study NCT ID:
NCT05528406
Status:
UNKNOWN
Last Update Posted:
2022-09-06
First Post:
2022-09-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Clinical Trial to Evaluate HLX208 in Advanced Solid Tumor Patients With BRAF V600 Mutation
Sponsor:
Shanghai Henlius Biotech
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-20
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-10-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-09-02
First Submit QC Date:
None
Study First Post Date:
2022-09-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-02
Last Update Post Date:
2022-09-06
Last Update Post Date Type:
ACTUAL